INT MEDICAL (01501) Proposes Full Circulation of H Shares

Stock News
2025/11/12

INT MEDICAL (01501) announced that the company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H shares. According to the CSRC filing, the company has applied on behalf of certain shareholders to convert a total of 71.7866 million domestic shares held by these shareholders into H shares and list them on the Hong Kong Stock Exchange (HKEX).

Upon obtaining all necessary filings and/or approvals from relevant regulatory authorities, including the CSRC and HKEX, and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and listed for trading on the Main Board of HKEX.

In accordance with the company's articles of association, no shareholders' meeting is required to approve the conversion and listing.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10